HealthyDirect · GrowthFit for a long SIP
BANDHAN Arbitrage Fund
- NAV
- 38.0582
- 29 Oct 2026
- 1Y
- +6.4%
- Trailing CAGR
- AUM
- ₹7,744.73 Cr
- 30 Sept 2026
- Volatility
- Low
- 1.0% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 60% of rolling 3-year windows.
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Watch
1.62% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -0.7%. Ask whether you can hold through a similar fall.
Vs category
Pass
60% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 117.7% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 1%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+6.4%
- 3Y+7.2%
- 5Y+6.7%
- 10Y+6.3%
- SI+6.9%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+6.2%
- 3Y+6.8%
- 5Y+7.0%
- 10Y+6.4%
- Since inception
- +6.9%
- Calendar-day CAGR
- Excess 1Y
- -0.2%
- Category median, same plan and option
- 3Y win rate
- +60%
- Windows beating the median
- 3Y percentile
- 50
- Vs comparable share classes
- SIP 3Y XIRR
- +6.8%
- Simulated monthly SIP
- Worst rolling 3Y
- +4.4%
- 2652 daily-ending windows
- Median rolling 3Y
- +6.7%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 2158 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -0.7%
- Worst peak-to-trough
- Current
- -0.2%
- Below last peak
- Current spell
- 6 days
- Days below latest peak
- Time below peak
- +43%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 2 days
- 779 recovered episodes
- Longest recovery
- 72 days
- Trough to prior peak
16 Mar 2020 – 20 Apr 2020
Trough 25 Mar 2020 · recovered in 26 days
-0.7%
29 May 2020 – 14 Aug 2020
Trough 3 Jun 2020 · recovered in 72 days
-0.6%
3 Aug 2026 – 24 Aug 2026
Trough 6 Aug 2026 · recovered in 18 days
-0.4%
1 Sept 2026 – 10 Sept 2026
Trough 4 Sept 2026 · recovered in 6 days
-0.3%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
50
Vs category
49
Consistency
56
Risk-adjusted
71
Drawdown
98
Mean
65
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 60% of rolling 3-year windows.
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 164 holdings · top 10 are 117.7%.
- Top 5
- 102.8%
- Top 10
- 117.7%
- Largest holding
- 70.2%
- Effective holdings
- 1.9
Net Current Assets
Unspecified
70.2%
Bandhan Money Market Fund Direct-Growth
Unspecified
13.5%
Bandhan Ultra Short to Short Term Fund Direct-Growth
Unspecified
8.9%
HDFC Bank Ltd
Financial
5.2%
Bandhan Ultra Short Duration Fund Direct-Growth
Unspecified
4.9%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Edelweiss Arbitrage Fund
Edelweiss Mutual Fund
- 1Y
- +6.6%
- 3Y
- +7.3%
- Vol
- 1.0%
- Max DD
- -0.5%
- Sharpe
- 0.82
- 3Y win
- +100%
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
Nippon India Arbitrage Fund
Nippon India Mutual Fund
- 1Y
- +6.6%
- 3Y
- +7.2%
- Vol
- 1.1%
- Max DD
- -0.6%
- Sharpe
- 1.00
- 3Y win
- +92%
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
Tata Arbitrage Fund
Tata Mutual Fund
- 1Y
- +6.6%
- 3Y
- +7.4%
- Vol
- 1.0%
- Max DD
- -0.6%
- Sharpe
- 0.52
- 3Y win
- +100%
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
Kotak Arbitrage Fund
Kotak Mahindra Mutual Fund
- 1Y
- +6.6%
- 3Y
- +7.4%
- Vol
- 1.0%
- Max DD
- -0.6%
- Sharpe
- 1.08
- 3Y win
- +81%
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Higher TER
quant Arbitrage Fund
quant Mutual Fund
- 1Y
- +7.5%
- 3Y
- n/a
- Vol
- 1.3%
- Max DD
- -0.4%
- Sharpe
- 0.96
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility